AUSSENWIRTSCHAFT AUSTRIA

International Health Day 2026

24–25 Mar 2026 | Vienna, Austria

HomeAgendaSpeakerMarketplaceContactEEN Support Offices
Register
Register
Register

InvestmentUpdated on 21 January 2026

Seed Investment in arterioscope

Hermann Moser

Co-Founder & CEO at arterioscope FlexCo

Graz, Austria

About

arterioscope FlexCo is a spin-off from Graz University of Technology developing an AI-powered digital biomarker platform for cardiovascular applications.

We are currently raising our first seed round to accelerate company growth and to bring our first digital biomarker module to market. Our technology enables the extraction of clinically relevant cardiovascular biomarkers from physiological signals, creating scalable digital endpoints for research and clinical use.

The company is presently financed mainly through public funding. We are now seeking our first private investment to leverage existing grants, finalize MDR certification, expand the team, and prepare the market entry in order to generate first commercial revenues.

If you are interested in an investment opportunity or a strategic exchange, please contact us directly or email hello@arterioscope.com.

Stage

  • Seed and Development

Applies to

  • Biology/Biotechnology
  • Pharmaceuticals
  • E-Health
  • Diagnostics

Organisation

arterioscope FlexCo

Medtech company

Graz, Austria

Similar opportunities